GlassScriptPrepare for your visit
Ronald F Klinger
Neurology (Psychiatry & Neurology) · Amityville, NY · NPI 1811962624
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,468.57
in general payments reported to CMS, 2019-2025 · $1,439 in 2025
The $1,439 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Who reported paying
General payments only, top 6 by amount.
- Lundbeck LLC $317.72
- Argenx US, INC. $306.09
- Boehringer Ingelheim Pharmaceuticals, INC. $219.38
- Neurocrine Biosciences, INC. $216.37
- Pfizer INC. $185.79
- Medtronic, INC. $164.86
Drugs and devices associated with these payments
Jardiance Vyvgart Vyepti Verquvo Linq II Octagam Immune Globulin (Human) Panzyga Rystiggo Repatha Ingrezza Ponvory Ultomiris
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Ronald Klinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/127939/ronald-f-klinger